Alessia Moioli

Verona, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Refining risk stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches.

Refining risk stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches.

Journal: Expert review of hematology
Published: August 05, 2026

Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy.

Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy.

Journal: British journal of haematology
Published: May 15, 2026

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

Journal: Blood advances
Published: April 16, 2026

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Journal: Leukemia & lymphoma
Published: January 29, 2026

Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Journal: Cancers
Published: November 20, 2025

TP53 Mutations in Mantle Cell Lymphoma: From Backup to Game Changer.

TP53 Mutations in Mantle Cell Lymphoma: From Backup to Game Changer.

Journal: Journal of clinical medicine
Published: October 09, 2025

We are on the right track for mantle cell lymphoma.

We are on the right track for mantle cell lymphoma.

Journal: British journal of haematology
Published: June 19, 2025

Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.

Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.

Journal: The Lancet. Haematology
Published: April 28, 2025

Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study.

Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study.

Journal: Leukemia research
Published: March 05, 2025

Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma.

Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma.

Journal: British journal of haematology
Published: September 04, 2024

Visceral Leishmaniasis Following A+AVD Treatment in a Patient with Classical Hodgkin's Lymphoma: A Case Report and Review of the Literature.

Visceral Leishmaniasis Following A+AVD Treatment in a Patient with Classical Hodgkin's Lymphoma: A Case Report and Review of the Literature.

Journal: Journal of clinical medicine
Published: August 13, 2024

Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report.

Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report.

Journal: Annals of hematology
Published: June 29, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026